<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Adverse events related to endoscopic retrograde cholangiopancreatography (ERCP) in adults</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Adverse events related to endoscopic retrograde cholangiopancreatography (ERCP) in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Adverse events related to endoscopic retrograde cholangiopancreatography (ERCP) in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andrea Tringali, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Guido Costamagna, MD, FACG</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John R Saltzman, MD, FACP, FACG, FASGE, AGAF</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen M Robson, MD, MBA, FACG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 31, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Endoscopic retrograde cholangiopancreatography (ERCP) is an advanced endoscopic procedure in which a specialized side-viewing upper endoscope is guided into the duodenum, allowing for instruments to be passed through the ampulla of Vater and into the biliary and pancreatic ducts. The ducts are opacified by injecting a contrast medium, thereby achieving radiographic imaging and facilitating endoscopic therapy. ERCP-guided interventions are used for managing a variety of pancreaticobiliary disorders (eg, removal of bile duct stones, relief of biliary obstruction). </p><p>ERCP is a complex procedure that requires specialized training and experience, and it is associated with higher rates of serious adverse events than other endoscopic procedures (eg, upper endoscopy, colonoscopy). It is important to use strategies to prevent ERCP-related adverse events and to recognize adverse events early so that treatment can be initiated.</p><p>This topic will discuss adverse events related to ERCP. Other aspects of ERCP including indications, patient preparation, and post-procedure care is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/632.html" rel="external">"Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults"</a>.)</p><p>Adverse events related to stent placement are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>Biliary stents – (See  <a class="medical medical_review" href="/z/d/html/13925.html" rel="external">"Endoscopic stenting for malignant biliary obstruction"</a> and  <a class="medical medical_review" href="/z/d/html/637.html" rel="external">"Endoscopic management of postcholecystectomy biliary complications"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pancreatic stents – (See  <a class="medical medical_review" href="/z/d/html/2658.html" rel="external">"Pancreatic stenting at endoscopic retrograde cholangiopancreatography (ERCP): Indications, techniques, and complications"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">INCIDENCE</span><span class="headingEndMark"> — </span>ERCP is generally regarded as a safe procedure. However, ERCP has been associated with a higher rate of adverse events than most other endoscopic procedures despite technologic advances, adherence to safety protocols, and advanced endoscopy training programs [<a href="#rid1">1</a>].  </p><p>Reported overall rates of ERCP-related adverse events have ranged from 5 to 12 percent, and mortality rates have ranged from 0.1 to 1.4 percent [<a href="#rid2">2-7</a>]. As an example, in a systematic review of 21 studies involving 16,855 patients who underwent ERCP, the overall complication rate was 7 percent, and the rate of serious complications was 2 percent [<a href="#rid6">6</a>]. </p><p>Despite technologic progress and safety measures, rates of procedure-related mortality have not decreased over time [<a href="#rid8">8</a>]. One possible reason is that ERCP has evolved into mainly a therapeutic procedure; thus, the procedure-related risks include those associated with the diagnostic examination and related interventions. </p><p>Data have suggested that all-cause mortality rates beyond 30 days post-ERCP were higher compared with rates within the 30-day window; however, deaths were most often related to underlying disease. In a registry study including over 16,000 patients who underwent ERCP, all-cause mortality rates at three months post-ERCP were higher compared with rates within 30 days (12 versus 5 percent) [<a href="#rid9">9</a>]. Most deaths that occurred beyond 30 days post-procedure were due to cancer (75 percent) [<a href="#rid9">9</a>]. </p><p class="headingAnchor" id="H256256559"><span class="h1">RISK FACTORS</span><span class="headingEndMark"> — </span>Some ERCP-related events are due to the effect of procedural sedation (eg, hypotension), while others are due to the endoscopy itself or to an intervention. </p><p>Observational studies have identified and classified risk factors for ERCP-related adverse events [<a href="#rid5">5,8,10-19</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Procedure-related factors (eg, difficult cannulation, precut [access] sphincterotomy). (See  <a class="medical medical_review" href="/z/d/html/675.html" rel="external">"Management of difficult biliary access during ERCP in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patient-related factors (eg, surgically-altered anatomy, sphincter of Oddi dysfunction, periampullary diverticulum, cirrhosis, older age, end-stage kidney disease).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hospital- and advanced endoscopist-related factors (eg, low ERCP case volume, procedure timing for selected conditions [eg, acute cholangitis]) [<a href="#rid20">20</a>]. </p><p></p><p class="bulletIndent1">Hospital and endoscopist procedure volume has been linked to risk of adverse events [<a href="#rid21">21-23</a>]. In a systematic review including 13 studies and nearly 60,000 ERCPs, higher endoscopist-related procedure volume was associated with lower risk of adverse events compared with lower procedure volume (ie, ranging from &lt;25 to &lt;156 ERCPs annually) (odds ratio [OR] 0.65; 95% CI 0.50-0.83) [<a href="#rid22">22</a>]. </p><p></p><p>Adverse events related to ERCP have also been characterized based on the following factors [<a href="#rid24">24,25</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Location – Adverse events may be focal, occurring at the point of endoscopic contact (eg, perforation, bleeding, pancreatitis), or they may affect an organ system (eg, cardiopulmonary) that was not accessed by the endoscope or its related devices.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Timing – Adverse events may occur early (typically within 30 days after the procedure) or late (beyond 30 days). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severity – The severity of adverse events can be assessed by duration and type of hospital stay (eg, intensive care unit); blood transfusion requirement; need for surgical, radiologic, or endoscopic interventions; and rates of morbidity and mortality [<a href="#rid25">25</a>]. </p><p></p><p class="headingAnchor" id="H1937404038"><span class="h1">COMMON ADVERSE EVENTS</span><span class="headingEndMark"> — </span>The most frequently encountered adverse events related to ERCP are pancreatitis, bleeding, infection, and perforation [<a href="#rid2">2-5,7</a>].</p><p class="headingAnchor" id="H125668158"><span class="h2">Pancreatitis</span><span class="headingEndMark"> — </span>Acute pancreatitis is a serious adverse event of ERCP that may result from mechanical injury to the pancreatic duct, hydrostatic injury from contrast injection, or guidewire manipulation. Risk factors, prevention, and management of post-ERCP pancreatitis are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/629.html" rel="external">"Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis"</a>.)</p><p class="headingAnchor" id="H34323217"><span class="h2">Bleeding</span><span class="headingEndMark"> — </span>Bleeding during ERCP is typically related to instrumentation such as biliary and/or pancreatic sphincterotomy. Prevention and management of post-ERCP bleeding are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/636.html" rel="external">"Post-endoscopic retrograde cholangiopancreatography (ERCP) bleeding"</a>.)</p><p class="headingAnchor" id="H838042301"><span class="h2">Perforation</span><span class="headingEndMark"> — </span>ERCP may be complicated by perforation of the esophagus, stomach, duodenum, or bilio-pancreatic area. The risk factors, diagnosis, and management of post-ERCP perforation are presented separately. (See  <a class="medical medical_review" href="/z/d/html/634.html" rel="external">"Post-ERCP perforation"</a>.)</p><p class="headingAnchor" id="H2989121166"><span class="h2">Infection</span><span class="headingEndMark"> — </span>Infections occurring after ERCP may be related to incomplete drainage of an infected biliary system, obstruction of the cystic duct, infected pancreatic fluid collection, or rarely, contaminated endoscopic equipment. The prevention and management of infectious complications related to ERCP are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/641.html" rel="external">"Infectious adverse events related to endoscopic retrograde cholangiopancreatography (ERCP)"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2672.html" rel="external">"Preventing infection transmitted by gastrointestinal endoscopy"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2545.html" rel="external">"Antibiotic prophylaxis for gastrointestinal endoscopic procedures"</a>.)</p><p></p><p class="headingAnchor" id="H3"><span class="h2">Anesthesia-related events</span><span class="headingEndMark"> — </span>Anesthesia-related events are commonly reported but most are transient and managed without further complications [<a href="#rid26">26-28</a>]. In a cohort study including 528 patients undergoing ERCP, 120 sedation-related adverse events (eg, hypotension, hypoxemia) were reported (25 percent), but these events were generally minor and rarely resulted in termination of the procedure [<a href="#rid27">27</a>]. Complications related to procedural sedation and anesthesia are discussed in more detail separately [<a href="#rid29">29</a>]. (See  <a class="medical medical_review" href="/z/d/html/105511.html" rel="external">"Anesthesia for gastrointestinal endoscopy in adults", section on 'Complications'</a> and  <a class="medical medical_review" href="/z/d/html/2599.html" rel="external">"Adverse events related to procedural sedation for gastrointestinal endoscopy in adults"</a>.)</p><p class="headingAnchor" id="H1157034693"><span class="h1">LESS COMMON ADVERSE EVENTS</span></p><p class="headingAnchor" id="H3888039877"><span class="h2">Accessory-related issues</span></p><p class="headingAnchor" id="H1735428173"><span class="h3">Impaction of a stone retrieval basket</span><span class="headingEndMark"> — </span>During ERCP-guided extraction of difficult bile duct stones  (<a class="graphic graphic_table graphicRef138304" href="/z/d/graphic/138304.html" rel="external">table 1</a>), the basket/stone apparatus may rarely become trapped in the biliary tree, typically at the ampulla within the intraduodenal portion of the common bile duct  (<a class="graphic graphic_diagnosticimage graphicRef142795" href="/z/d/graphic/142795.html" rel="external">image 1</a>). Basket entrapment in other locations (eg, proximal bile duct, intrahepatic ducts, main pancreatic duct) has also been reported [<a href="#rid30">30,31</a>].</p><p>Risk factors for basket entrapment include large, irregularly shaped and/or multiple stones, in addition to a small sphincterotomy size. Other risk factors are distal narrowing of the common bile duct and segmental dilation of intrahepatic ducts (eg, Caroli disease). (See  <a class="medical medical_review" href="/z/d/html/650.html" rel="external">"Caroli disease", section on 'Patients with choledocholithiasis and cholangitis'</a>.)</p><p>Techniques for using a basket device and measures to reduce the risk of basket entrapment are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/674.html" rel="external">"Endoscopic management of bile duct stones", section on 'Patients with complicated stones'</a>.)</p><p>Management of basket retention is individualized and informed by location of impaction, endoscopist preference, and equipment availability [<a href="#rid32">32-34</a>]. We may use mechanical lithotripsy to fragment the stone in addition to extending the sphincterotomy or performing sphincteroplasty, and these methods are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/674.html" rel="external">"Endoscopic management of bile duct stones", section on 'Fragmenting the stones'</a> and  <a class="medical medical_review" href="/z/d/html/631.html" rel="external">"Endoscopic balloon dilation for removal of bile duct stones"</a> and  <a class="medical medical_review" href="/z/d/html/640.html" rel="external">"Endoscopic biliary sphincterotomy"</a>.)</p><p>Other nonsurgical interventions include cholangioscopy-guided electrohydraulic lithotripsy or laser lithotripsy:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/633.html" rel="external">"Cholangioscopy and pancreatoscopy"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/639.html" rel="external">"Electrohydraulic lithotripsy in the treatment of bile and pancreatic duct stones"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/647.html" rel="external">"Laser lithotripsy for the treatment of bile duct stones"</a>.)</p><p></p><p>When advanced endoscopic methods are unsuccessful or unavailable, surgical intervention with common bile duct exploration is needed [<a href="#rid33">33</a>]. </p><p>For patients with incomplete clearance of the bile duct, we establish biliary drainage by placing a temporary stent. (See  <a class="medical medical_review" href="/z/d/html/674.html" rel="external">"Endoscopic management of bile duct stones", section on 'Patients with incomplete duct clearance'</a>.)</p><p class="headingAnchor" id="H1978419125"><span class="h3">Events related to wire-guided cannulation</span><span class="headingEndMark"> — </span>Rare guidewire-related adverse events include:</p><p class="bulletIndent1"><span class="glyph">●</span>Inadvertent cannulation – Advancing the guidewire inadvertently through the bile or pancreatic duct and into the liver or pancreatic parenchyma or into an adjacent vessel may result in bleeding, hematoma, bile leak, or pancreatitis [<a href="#rid35">35-39</a>]. However, perforation of the bile or pancreatic duct rarely occurs because wire-guided cannulation is performed under fluoroscopic guidance. If a small ductal perforation occurs, we immediately remove the guidewire and observe the patient for complications such as bleeding and peritonitis. Most patients recover without the need for surgery [<a href="#rid39">39</a>]. (See <a class="local">'Extraluminal bleeding and hematomas'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Guidewire fracture – Guidewire fracture during ERCP has been reported rarely [<a href="#rid38">38,40-43</a>]. Limited studies suggested that guidewire fragments retained within the pancreatic or biliary ducts may be removed endoscopically without the need for surgery [<a href="#rid40">40,41,43</a>]. </p><p></p><p class="headingAnchor" id="H501785932"><span class="h3">Stent-related issues</span><span class="headingEndMark"> — </span>Adverse events related to stent placement (eg, stent migration, stent occlusion) are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>Biliary stents – (See  <a class="medical medical_review" href="/z/d/html/13925.html" rel="external">"Endoscopic stenting for malignant biliary obstruction", section on 'Stent-related'</a> and  <a class="medical medical_review" href="/z/d/html/637.html" rel="external">"Endoscopic management of postcholecystectomy biliary complications"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pancreatic stents – (See  <a class="medical medical_review" href="/z/d/html/2658.html" rel="external">"Pancreatic stenting at endoscopic retrograde cholangiopancreatography (ERCP): Indications, techniques, and complications", section on 'Adverse events'</a>.)</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Contrast allergy and other contrast-related issues</span><span class="headingEndMark"> — </span>Adverse reactions to contrast agents used during ERCP are very rare because contrast agents are not injected intravenously but instead are used to opacify the biliary and pancreatic ducts [<a href="#rid44">44-47</a>]. In a study of 1766 patients who underwent a total of 2295 ERCPs, one adverse reaction to contrast (ie, a diffuse pruritic rash) was reported, but there were no cases of anaphylaxis [<a href="#rid45">45</a>]. In addition, no adverse reactions related to contrast media occurred in 127 procedures performed in patients with a history of iodine allergy. Most procedures (95 percent) were performed without premedication prophylaxis. </p><p>Thus, use of premedication varies in clinical practice because it is uncertain whether it is beneficial for preventing adverse reactions related to contrast. We reserve the use of premedication for patients with a history of anaphylaxis or severe adverse reaction (eg, bronchospasm, diffuse erythema with hypotension) related to iodinated contrast. The premedication regimens are similar to prophylaxis for patients undergoing computed tomography with iodinated contrast and involve administration of an antihistamine and glucocorticoid  (<a class="graphic graphic_table graphicRef59096" href="/z/d/graphic/59096.html" rel="external">table 2</a>). The timing of ERCP (urgent or elective) also informs drug dosing and administration, and these issues are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/113083.html" rel="external">"Patient evaluation prior to oral or iodinated intravenous contrast for computed tomography"</a>.)</p><p>We do not typically use premedication for patients with a history of nonsevere reaction to iodinated contrast (eg, limited rash, pruritus, cutaneous edema or flushing) [<a href="#rid45">45</a>]. </p><p>Extravasation of contrast into the duodenal wall surrounding the papilla during ERCP may interfere with successful biliary cannulation, prolong the procedure, and possibly increase the risk of adverse events [<a href="#rid11">11,48</a>]. In addition, injecting contrast inadvertently into a vascular structure may create diagnostic uncertainty and increase the risk of sepsis, gas embolism, bleeding, or thrombosis. As an example, a portal vein that has been opacified with contrast may be misinterpreted as an incompletely filled bile duct  (<a class="graphic graphic_picture graphicRef129114" href="/z/d/graphic/129114.html" rel="external">picture 1</a>)<strong>.</strong></p><p>If contrast is inadvertently injected into a vascular structure, we terminate the ERCP and monitor the patient for adverse events such as bleeding or infection.<strong> </strong></p><p class="headingAnchor" id="H5"><span class="h2">Dysfunction of implanted cardiac devices</span><span class="headingEndMark"> — </span>During procedures involving an electrosurgery unit, the function of a cardiac implantable electronic device (CIED) may be affected by electromagnetic interference (EMI). EMI refers to the potential dysfunction of an electronic device when it is in the vicinity of an electromagnetic field generated by an external source. During ERCP with sphincterotomy, we use monopolar current from an electrosurgical unit. </p><p>Patients with CIEDs (ie, pacemakers or implantable cardioverter defibrillators) undergo a preprocedure evaluation to assess compatibility with use of an electrosurgery unit  (<a class="graphic graphic_table graphicRef105464" href="/z/d/graphic/105464.html" rel="external">table 3</a>). Periprocedural management of patients with implanted cardiac devices who undergo procedures involving electrosurgery is discussed in more detail separately. (See  <a class="medical medical_review" href="/z/d/html/94293.html" rel="external">"Perioperative management of patients with a pacemaker or implantable cardioverter-defibrillator"</a>.)</p><p>Data have suggested that use of an electrosurgery unit during endoscopy rarely impacts the function of cardiac implanted electronic devices [<a href="#rid49">49-52</a>]. In a database study including over 40,000 reports of CIED dysfunction, 45 reports (approximately 0.1 percent) were related to use of electrocautery during an endoscopic procedure. Events related to electromagnetic interference included inappropriate shocks, pacing inhibition resulting in bradycardia or asystole, device damage requiring replacement, and rarely, ventricular tachycardia [<a href="#rid50">50</a>]. Although most pacemakers are not affected by short bursts of electrocautery, cardiac arrhythmias can develop if a monopolar current passes through the pacemaker or the heart. In addition, electrocautery may trigger activation of an implantable cardioverter defibrillator. </p><p class="headingAnchor" id="H128136240"><span class="h2">Extraluminal bleeding and hematomas</span><span class="headingEndMark"> — </span>Bleeding after ERCP is usually related to endoscopic sphincterotomy and thus involves bleeding into the duodenal lumen. (See  <a class="medical medical_review" href="/z/d/html/636.html" rel="external">"Post-endoscopic retrograde cholangiopancreatography (ERCP) bleeding"</a>.)</p><p>However, rare causes of post-ERCP bleeding have been related to the following conditions:</p><p class="bulletIndent1"><span class="glyph">●</span>Splenic or liver injury – Cases of splenic, hepatic, or other intrabdominal injury resulting in bleeding have been reported following ERCP [<a href="#rid53">53-63</a>]. The proposed mechanism of injury is related to excessive manipulation and/or looping of the endoscope within the stomach while advancing it into the duodenum. The manifestations of splenic injury vary from a subcapsular hematoma to rupture of splenic vessels. As a result, some patients will develop hemodynamic instability and/or acute abdomen, but other patients will have less severe symptoms. The diagnosis of a subcapsular splenic laceration should be suspected in patients who develop acute left upper quadrant abdominal pain following ERCP. The pain is often delayed (ie, &gt;24 hours after the procedure) and is not always associated with signs of peritoneal irritation, hemodynamic instability, or a drop in hemoglobin. Similarly, subcapsular hepatic hematoma is a potentially serious complication, and may be related to use of a guidewire [<a href="#rid55">55-57</a>]. (See <a class="local">'Accessory-related issues'</a> above.) </p><p></p><p class="bulletIndent1">For patients with suspected intra-abdominal bleeding, the initial evaluation includes imaging with computed tomography (CT) scan with angiography in addition to selective angiographic intervention for the culprit vessel. For some patients, surgical intervention may be required to achieve hemostasis if the bleeding cannot be controlled with angiographic methods. (See  <a class="medical medical_review" href="/z/d/html/15143.html" rel="external">"Management of hepatic trauma in adults"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Biliary varices – Bleeding from bile duct varices during ERCP has been reported following sphincterotomy and dilation of a distal common bile duct stricture in a patient with cirrhosis and cavernous transformation of the portal vein [<a href="#rid64">64-66</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bleeding related to stent placement – Bleeding related to biliary or pancreatic stent placement is uncommon but may result from the stent becoming impacted in or irritating the opposing duodenal wall. Stent-related bleeding from mucosal damage in the distal small bowel or colon has also been reported as a result of stent migration [<a href="#rid67">67</a>]. In addition, self-expandable metal stents may rarely cause hemobilia related to a pseudoaneurysm that formed an arterio-biliary fistula [<a href="#rid68">68,69</a>]. Pseudoaneurysms have also been reported in patients with difficult biliary access requiring precut sphincterotomy followed by plastic stent placement [<a href="#rid70">70</a>]. </p><p></p><p class="bulletIndent1">During stent placement, acute bleeding may be related to vascular injury (eg, communication with the portal vein). For such patients, we place a fully covered, self-expandable metal stent (SEMS) to tamponade the bleeding and cover the fistula tract. For patients with refractory bleeding despite stenting, management is similar to patients with refractory post-sphincterotomy bleeding with subsequent options including angiographic embolization or surgery [<a href="#rid71">71</a>]. (See  <a class="medical medical_review" href="/z/d/html/636.html" rel="external">"Post-endoscopic retrograde cholangiopancreatography (ERCP) bleeding", section on 'Refractory bleeding'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intramural injury – Intramural hematoma of the upper esophagus as a result of ERCP has been reported [<a href="#rid72">72</a>]. The risk of injury to the esophageal wall may be increased with ERCP because visualization of the esophageal mucosa is limited during side-viewing endoscopy. </p><p></p><p class="headingAnchor" id="H369998908"><span class="h2">Gas embolism</span></p><p class="headingAnchor" id="H4201877076"><span class="h3">Epidemiology and risk factors</span><span class="headingEndMark"> — </span>Gas embolism is a rare but potentially catastrophic event resulting from communication of the vasculature with external pressure from the gastrointestinal lumen or bile duct that allows gas to enter the circulation [<a href="#rid73">73,74</a>]. The embolized gas is typically carbon dioxide because most endoscopists use carbon dioxide for insufflation during ERCP. (See  <a class="medical medical_review" href="/z/d/html/632.html" rel="external">"Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults", section on 'Gas insufflation'</a>.) </p><p>Most cases of gas embolism related to endoscopic procedures involve ERCP, although some case reports have been related to upper or lower gastrointestinal endoscopy [<a href="#rid75">75-80</a>]. As an example, in an analysis of an inpatient database including over two million endoscopic procedures, gas embolism occurred in 13 patients, resulting in a gas embolism rate of 0.57 per 100,000 endoscopies. Gas embolism was more common during ERCP compared with upper endoscopy or colonoscopy (3.32 per 100,000 procedures versus 0.44 and 0.38 per 100,000 procedures, respectively) [<a href="#rid78">78</a>]. However, the true incidence of gas embolism is uncertain because some cases may be subclinical and thus go unreported [<a href="#rid81">81</a>]. Males and females appear to be affected equally [<a href="#rid79">79</a>].</p><p>Risk factors for gas embolism may be classified as follows [<a href="#rid82">82-85</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Procedure-related factors – Intraductal endoscopy using small caliber endoscopes (eg, cholangioscopy), gas insufflation using higher pressures during prolonged procedures, or use of a rendezvous technique for establishing biliary access. (See  <a class="medical medical_review" href="/z/d/html/2653.html" rel="external">"Therapeutic endoscopic ultrasound", section on 'EUS-guided cholangiopancreatography'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patient-related factors – Prior hepatobiliary intervention (eg, hepatobiliary surgery, liver biopsy, percutaneous transhepatic cholangiography with biliary drain(s), transjugular intrahepatic portosystemic shunt [TIPS]), history of blunt or penetrating trauma to the liver, or history of liver abscesses/tumor.</p><p></p><p>Possible protective/mitigating factors include:</p><p class="bulletIndent1"><span class="glyph">●</span>Carbon dioxide insufflation – We routinely use carbon dioxide for gas insufflation during ERCP because the consequences of gas embolism may be mitigated with use of carbon dioxide rather than air insufflation [<a href="#rid86">86</a>]. Carbon dioxide is rapidly absorbed by the gastrointestinal mucosa and delivered to the lungs by the circulation, whereas ambient air is not readily absorbed. Thus, carbon dioxide is more rapidly eliminated if embolism occurs. (See  <a class="medical medical_review" href="/z/d/html/105511.html" rel="external">"Anesthesia for gastrointestinal endoscopy in adults", section on 'Complications'</a>.)</p><p></p><p class="bulletIndent1">Other aspects of carbon dioxide insufflation for gastrointestinal procedures are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/632.html" rel="external">"Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults", section on 'Gas insufflation'</a> and  <a class="medical medical_review" href="/z/d/html/13927.html" rel="external">"Overview of colonoscopy in adults", section on 'Colonoscope advancement and mucosal inspection'</a>.)</p><p></p><p class="headingAnchor" id="H1833629593"><span class="h3">Types of gas embolism and pathogenesis</span><span class="headingEndMark"> — </span>Gas embolism may be venous or arterial [<a href="#rid79">79</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A venous gas embolism occurs when gas passes from the portal vein to the systemic venous circulation through the hepatic veins and then to the right ventricle and pulmonary circulation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An arterial gas embolism occurs when gas in the venous system enters the arterial system through a patent foramen ovale or pulmonary arteriovenous shunts; it may also occur in the absence of a shunt if the rate and volume of gas entry exceeds the filtering capacity of the lung.</p><p></p><p>Possible mechanisms for gas embolism during an endoscopic procedure include:</p><p class="bulletIndent1"><span class="glyph">●</span>Insufflating the gastrointestinal lumen with gas under pressure leads to gas entering veins that are exposed because of a compromised mucosal barrier (eg, mucosal irritation, ulceration).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Gas enters a previously established communication between the biliary system and the circulation (eg, bilio-venous fistula).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>During intraductal biliary endoscopy (eg, cholangioscopy), gas enters a hepatic vein.</p><p></p><p class="headingAnchor" id="H697744597"><span class="h3">Clinical presentation</span><span class="headingEndMark"> — </span>Clinical presentation of gas embolism ranges from patients with no or minimal symptoms from a minor venous gas embolism to respiratory compromise, ventricular arrhythmias, and cardiac arrest in severe cases [<a href="#rid79">79</a>]. The specific clinical manifestations depend on the rapidity and amount of gas entering the circulation in addition to underlying comorbidities  (<a class="graphic graphic_table graphicRef76772" href="/z/d/graphic/76772.html" rel="external">table 4</a>) [<a href="#rid87">87,88</a>]. (See  <a class="medical medical_review" href="/z/d/html/8263.html" rel="external">"Air embolism"</a>.)</p><p>During ERCP, the onset or exacerbation of symptoms may occur when changing the patient's position from the typical prone positioning to a supine position. (See  <a class="medical medical_review" href="/z/d/html/105511.html" rel="external">"Anesthesia for gastrointestinal endoscopy in adults"</a>.)</p><p class="headingAnchor" id="H136375274"><span class="h3">Diagnosis and management</span><span class="headingEndMark"> — </span>Gas embolism should be suspected in patients who develop sudden hemodynamic collapse during or immediately following an endoscopic procedure. When gas embolism is suspected, the procedure is terminated immediately in addition to administering 100 percent oxygen, and turning the patient to the left lateral decubitus position, head down. Management of gas embolism during ERCP is similar to other settings as shown in the table  (<a class="graphic graphic_table graphicRef120289" href="/z/d/graphic/120289.html" rel="external">table 5</a>). (See  <a class="medical medical_review" href="/z/d/html/114424.html" rel="external">"Intraoperative venous air embolism during neurosurgery", section on 'Management of intraoperative VAE'</a>.)</p><p>While rare, endoscopy-related gas embolism has been associated with high mortality rates. In a large database study including patients undergoing gastrointestinal endoscopy, gas embolism occurred rarely (0.57 per 100,000 procedures) but the mortality rate among patients with gas embolism was 15 percent [<a href="#rid78">78</a>].</p><p class="headingAnchor" id="H4217435385"><span class="h3">Prevention</span><span class="headingEndMark"> — </span>Strategies to reduce the risk of gas embolism include [<a href="#rid63">63</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Continuous cardiopulmonary monitoring to promote early detection</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Avoiding ERCP in patients with suspected or known biliary-vascular fistula </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use of carbon dioxide insufflation for ERCP (see <a class="local">'Epidemiology and risk factors'</a> above)</p><p></p><p class="headingAnchor" id="H13"><span class="h2">Pneumothorax</span><span class="headingEndMark"> — </span>Pneumothorax (gas in the pleural space) or other gas leak (eg, subcutaneous emphysema, pneumoperitoneum) with or without gastrointestinal perforation has been rarely reported following ERCP and other endoscopic procedures [<a href="#rid89">89-91</a>]. The mechanism of injury leading to pneumothorax in the absence of perforation is a rise in airway and intra-alveolar pressure leading to rupture of pulmonary blebs. (See  <a class="medical medical_review" href="/z/d/html/6706.html" rel="external">"Pneumothorax in adults: Epidemiology and etiology"</a>.)</p><p>Pneumothorax should be suspected in patients with acute dyspnea and pleuritic chest pain. Management depends on the size of the pneumothorax and associated symptoms. These issues are addressed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/117242.html" rel="external">"Clinical presentation and diagnosis of pneumothorax"</a> and  <a class="medical medical_review" href="/z/d/html/117232.html" rel="external">"Treatment of primary spontaneous pneumothorax in adults"</a>.)</p><p>Data on pneumothorax related to ERCP are limited to case reports. In a systematic review of 44 studies including patients undergoing ERCP, a total of 49 cases of pneumothorax were reported [<a href="#rid90">90</a>]. Twenty-one patients (43 percent) had altered gastrointestinal anatomy (eg, periampullary diverticula, surgically altered anatomy). Pneumothorax occurred bilaterally in 22 patients (45 percent). The cause of pneumothorax in most cases was duodenal perforation at a periampullary site in 20 procedures (41 percent) or distal to the papilla in 11 procedures (23 percent). Most patients with pneumothorax (80 percent) were diagnosed within six hours of ERCP, and 30 patients underwent pleural drainage.</p><p class="headingAnchor" id="H1567379295"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/118263.html" rel="external">"Society guideline links: Endoscopic retrograde cholangiopancreatography (ERCP)"</a>.)</p><p class="headingAnchor" id="H4676219"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Background and incidence</strong> – ERCP is generally regarded as a safe procedure. However, ERCP is associated with higher rates of adverse events than other endoscopic procedures despite technologic advances, adherence to safety protocols, and advanced endoscopic training programs. Reported overall rates of ERCP-related adverse events have ranged from 5 to 12 percent, and mortality rates have ranged from 0.1 to 1.4 percent. (See <a class="local">'Incidence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Risk factors for ERCP-related complications include (see <a class="local">'Risk factors'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Procedure-related factors (eg, difficult cannulation, precut [access] sphincterotomy) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patient-related factors (eg, surgically altered anatomy, sphincter of Oddi dysfunction, periampullary diverticulum, comorbidities such as older age and cirrhosis) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hospital- and advanced endoscopist-related factors (eg, low ERCP case volume, procedure timing for selected conditions [eg, acute cholangitis])</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Common adverse events</strong> – The most frequently encountered serious post-ERCP adverse events are:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pancreatitis (see  <a class="medical medical_review" href="/z/d/html/629.html" rel="external">"Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Bleeding (see  <a class="medical medical_review" href="/z/d/html/636.html" rel="external">"Post-endoscopic retrograde cholangiopancreatography (ERCP) bleeding"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Infection (see  <a class="medical medical_review" href="/z/d/html/641.html" rel="external">"Infectious adverse events related to endoscopic retrograde cholangiopancreatography (ERCP)"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Perforation (see  <a class="medical medical_review" href="/z/d/html/634.html" rel="external">"Post-ERCP perforation"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Less common adverse events</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Accessory-related adverse events – Uncommon adverse events involving ERCP accessories include impaction of a stone retrieval basket  (<a class="graphic graphic_diagnosticimage graphicRef142795" href="/z/d/graphic/142795.html" rel="external">image 1</a>) and guidewire-related injuries (eg, inadvertent cannulation of intra-abdominal organs or vessels). (See <a class="local">'Accessory-related issues'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Contrast allergy – Adverse reactions to contrast agents for ERCP are very rare because contrast agents are not injected intravenously but instead are used to opacify the biliary and pancreatic ducts. (See <a class="local">'Contrast allergy and other contrast-related issues'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Gas embolism – Gas embolism is a rare but potentially serious event. Gas embolism should be suspected in patients who develop sudden hemodynamic collapse during or immediately following ERCP. When gas embolism is suspected, the procedure is terminated immediately in addition to administering 100 percent oxygen and turning the patient to the left lateral decubitus position, head down. Management of gas embolism during ERCP is similar to other settings as shown in the table  (<a class="graphic graphic_table graphicRef120289" href="/z/d/graphic/120289.html" rel="external">table 5</a>). (See <a class="local">'Gas embolism'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pneumothorax and other air leaks – Pneumothorax (gas in the pleural space) or other gas leak (eg, subcutaneous emphysema, pneumoperitoneum) with or without gastrointestinal perforation has been rarely reported following ERCP. Pneumothorax should be suspected in patients with acute dyspnea and pleuritic chest pain. Management depends on the size of the pneumothorax and associated symptoms. These issues are addressed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/117242.html" rel="external">"Clinical presentation and diagnosis of pneumothorax"</a> and  <a class="medical medical_review" href="/z/d/html/117232.html" rel="external">"Treatment of primary spontaneous pneumothorax in adults"</a>.)</p><p></p><p class="headingAnchor" id="H3885576882"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledge Francesco Ferrara, MD, and Silvano Loperfido, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Trap R, Adamsen S, Hart-Hansen O, Henriksen M. Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective series of claims to insurance covering public hospitals. Endoscopy 1999; 31:125.</a></li><li><a class="nounderline abstract_t">Siiki A, Tamminen A, Tomminen T, Kuusanmäki P. ERCP procedures in a Finnish community hospital: a retrospective analysis of 1207 cases. Scand J Surg 2012; 101:45.</a></li><li><a class="nounderline abstract_t">Kapral C, Mühlberger A, Wewalka F, et al. Quality assessment of endoscopic retrograde cholangiopancreatography: results of a running nationwide Austrian benchmarking project after 5 years of implementation. Eur J Gastroenterol Hepatol 2012; 24:1447.</a></li><li><a class="nounderline abstract_t">Kienbauer M, Duller C, Gschwantler M, et al. [Austrian benchmarking project for ERCP: a 10-year report]. Z Gastroenterol 2018; 56:1227.</a></li><li><a class="nounderline abstract_t">Glomsaker T, Hoff G, Kvaløy JT, et al. Patterns and predictive factors of complications after endoscopic retrograde cholangiopancreatography. Br J Surg 2013; 100:373.</a></li><li><a class="nounderline abstract_t">Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007; 102:1781.</a></li><li><a class="nounderline abstract_t">Jang DK, Kim J, Paik CN, et al. Endoscopic retrograde cholangiopancreatography-related adverse events in Korea: A nationwide assessment. United European Gastroenterol J 2022; 10:73.</a></li><li><a class="nounderline abstract_t">Coelho-Prabhu N, Shah ND, Van Houten H, et al. Endoscopic retrograde cholangiopancreatography: utilisation and outcomes in a 10-year population-based cohort. BMJ Open 2013; 3.</a></li><li><a class="nounderline abstract_t">Kalaitzakis E. All-cause mortality after ERCP. Endoscopy 2016; 48:987.</a></li><li><a class="nounderline abstract_t">Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996; 335:909.</a></li><li><a class="nounderline abstract_t">Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998; 48:1.</a></li><li><a class="nounderline abstract_t">Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001; 96:417.</a></li><li><a class="nounderline abstract_t">Cotton PB, Garrow DA, Gallagher J, Romagnuolo J. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc 2009; 70:80.</a></li><li><a class="nounderline abstract_t">Williams EJ, Taylor S, Fairclough P, et al. Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy 2007; 39:793.</a></li><li><a class="nounderline abstract_t">Wang P, Li ZS, Liu F, et al. Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol 2009; 104:31.</a></li><li><a class="nounderline abstract_t">Vandervoort J, Soetikno RM, Tham TC, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002; 56:652.</a></li><li><a class="nounderline abstract_t">Christensen M, Matzen P, Schulze S, Rosenberg J. Complications of ERCP: a prospective study. Gastrointest Endosc 2004; 60:721.</a></li><li><a class="nounderline abstract_t">Sawas T, Bazerbachi F, Haffar S, et al. End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients. World J Gastroenterol 2018; 24:4691.</a></li><li><a class="nounderline abstract_t">Freeman ML. Adverse outcomes of ERCP. Gastrointest Endosc 2002; 56:S273.</a></li><li><a class="nounderline abstract_t">Buonocore MR, Germani U, Castellani D, et al. Timing of endoscopic therapy for acute bilio-pancreatic diseases: a practical overview. Ann Gastroenterol 2021; 34:125.</a></li><li><a class="nounderline abstract_t">Varadarajulu S, Kilgore ML, Wilcox CM, Eloubeidi MA. Relationship among hospital ERCP volume, length of stay, and technical outcomes. Gastrointest Endosc 2006; 64:338.</a></li><li><a class="nounderline abstract_t">Keswani RN, Qumseya BJ, O'Dwyer LC, Wani S. Association Between Endoscopist and Center Endoscopic Retrograde Cholangiopancreatography Volume With Procedure Success and Adverse Outcomes: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2017; 15:1866.</a></li><li><a class="nounderline abstract_t">Lee HJ, Cho CM, Heo J, et al. Impact of Hospital Volume and the Experience of Endoscopist on Adverse Events Related to Endoscopic Retrograde Cholangiopancreatography: A Prospective Observational Study. Gut Liver 2020; 14:257.</a></li><li><a class="nounderline abstract_t">Petersen BT. ERCP outcomes: defining the operators, experience, and environments. Gastrointest Endosc 2002; 55:953.</a></li><li><a class="nounderline abstract_t">Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2020; 52:127.</a></li><li><a class="nounderline abstract_t">Sharma VK, Nguyen CC, Crowell MD, et al. A national study of cardiopulmonary unplanned events after GI endoscopy. Gastrointest Endosc 2007; 66:27.</a></li><li><a class="nounderline abstract_t">Berzin TM, Sanaka S, Barnett SR, et al. A prospective assessment of sedation-related adverse events and patient and endoscopist satisfaction in ERCP with anesthesiologist-administered sedation. Gastrointest Endosc 2011; 73:710.</a></li><li><a class="nounderline abstract_t">Behrens A, Kreuzmayr A, Manner H, et al. Acute sedation-associated complications in GI endoscopy (ProSed 2 Study): results from the prospective multicentre electronic registry of sedation-associated complications. Gut 2019; 68:445.</a></li><li><a class="nounderline abstract_t">Lieber SR, Heller BJ, Martin CF, et al. Complications of Anesthesia Services in Gastrointestinal Endoscopic Procedures. Clin Gastroenterol Hepatol 2020; 18:2118.</a></li><li><a class="nounderline abstract_t">Cutler AF, Hassig WM, Schubert TT. Basket impaction at the pancreatic head. Gastrointest Endosc 1992; 38:520.</a></li><li><a class="nounderline abstract_t">Mutignani M, Gabbrielli A, Murali N, et al. Novel methods of management of trapped dormia baskets in the pancreatic and biliary ducts. Endoscopy 1997; 29:129.</a></li><li><a class="nounderline abstract_t">Benatta MA, Desjeux A, Barthet M, et al. Impacted and Fractured Biliary Basket: A Second Basket Rescue Technique. Case Rep Med 2016; 2016:6210646.</a></li><li><a class="nounderline abstract_t">O'Brien JW, Tyler R, Shaukat S, Harris AM. Laparoscopic Common Bile Duct Exploration for Retrieval of Impacted Dormia Basket following Endoscopic Retrograde Cholangiopancreatography with Mechanical Failure: Case Report with Literature Review. Case Rep Surg 2017; 2017:5878614.</a></li><li><a class="nounderline abstract_t">Feng Y, Zhu H, Chen X, et al. Comparison of endoscopic papillary large balloon dilation and endoscopic sphincterotomy for retrieval of choledocholithiasis: a meta-analysis of randomized controlled trials. J Gastroenterol 2012; 47:655.</a></li><li><a class="nounderline abstract_t">Kalaitzakis E, Stern N, Sturgess R. Portal vein cannulation: an uncommon complication of endoscopic retrograde cholangiopancreatography. World J Gastroenterol 2011; 17:5131.</a></li><li><a class="nounderline abstract_t">Kawakami H, Kuwatani M, Kudo T, et al. Portobiliary fistula: unusual complication of wire-guided cannulation during endoscopic retrograde cholangiopancreatography. Endoscopy 2011; 43 Suppl 2 UCTN:E98.</a></li><li><a class="nounderline abstract_t">Gottschalk U, Morgenstern C, Kadow K. [Accidental cannulation of the hepatic artery following needle-knife sphincterotomy]. Z Gastroenterol 2007; 45:702.</a></li><li><a class="nounderline abstract_t">Rabie ME, Al Faris S, Nasser A, et al. Parenchymal Guidewire Perforation during ERCP: An Unappreciated Injury. Case Rep Surg 2015; 2015:670323.</a></li><li><a class="nounderline abstract_t">Takano Y, Nagahama M, Yamamura E, et al. Perforation of the Papilla of Vater in Wire-Guided Cannulation. Can J Gastroenterol Hepatol 2016; 2016:5825230.</a></li><li><a class="nounderline abstract_t">Nishikawa Y, Uza N, Yamauchi Y, et al. Successful endoscopic removal of fractured guidewire fragments from a peripheral bile duct using a biliary stent delivery system and biopsy forceps. Endoscopy 2018; 50:E279.</a></li><li><a class="nounderline abstract_t">Mori Y, Kurita A. Successful retrieval of a fractured biliary guidewire using a newly developed endoscopic tapered sheath. Endoscopy 2023; 55:E706.</a></li><li><a class="nounderline abstract_t">Zejnullahu VA, Zejnullahu VA. Fractured guide wire in the main pancreatic duct during ERCP: A case report. Int J Surg Case Rep 2023; 102:107843.</a></li><li><a class="nounderline abstract_t">Kitagawa S. Successful Endoscopic Retrieval of a Retained Fractured Guidewire from the Main Pancreatic Duct. GE Port J Gastroenterol 2022; 29:364.</a></li><li><a class="nounderline abstract_t">Pan JJ, Draganov PV. Adverse reactions to iodinated contrast media administered at the time of endoscopic retrograde cholangiopancreatography (ERCP). Inflamm Allergy Drug Targets 2009; 8:17.</a></li><li><a class="nounderline abstract_t">Trottier-Tellier F, Harvey L, Baillargeon JD. Risk Evaluation of Endoscopic Retrograde Cholangiopancreatography-Related Contrast Media Allergic-Like Reaction: A Single Centre Experience. Can J Gastroenterol Hepatol 2018; 2018:6296071.</a></li><li><a class="nounderline abstract_t">Draganov PV, Forsmark CE. Prospective evaluation of adverse reactions to iodine-containing contrast media after ERCP. Gastrointest Endosc 2008; 68:1098.</a></li><li><a class="nounderline abstract_t">Mishkin D, Carpenter S, Croffie J, et al. ASGE Technology Status Evaluation Report: radiographic contrast media used in ERCP. Gastrointest Endosc 2005; 62:480.</a></li><li><a class="nounderline abstract_t">Katsinelos P, Pilpilidis I, Paroutoglou G, et al. Pyogenic cholangitis after inadvertent submucosal contrast injection in the papilla of Vater in a patient with cholestatic hepatitis. Surg Endosc 2003; 17:1677.</a></li><li><a class="nounderline abstract_t">Parekh PJ, Buerlein RC, Shams R, et al. An update on the management of implanted cardiac devices during electrosurgical procedures. Gastrointest Endosc 2013; 78:836.</a></li><li><a class="nounderline abstract_t">Samuels JM, Overbey DM, Wikiel KJ, et al. Electromagnetic interference on cardiac pacemakers and implantable cardioverter defibrillators during endoscopy as reported to the US Federal Drug Administration. Surg Endosc 2021; 35:3796.</a></li><li><a class="nounderline abstract_t">Barmore W, Patel H, Voong C, et al. Effects of medically generated electromagnetic interference from medical devices on cardiac implantable electronic devices: A review. World J Cardiol 2022; 14:446.</a></li><li><a class="nounderline abstract_t">Baeg MK, Kim SW, Ko SH, et al. Endoscopic Electrosurgery in Patients with Cardiac Implantable Electronic Devices. Clin Endosc 2016; 49:176.</a></li><li><a class="nounderline abstract_t">Gaffney RR, Jain V, Moyer MT. Splenic Injury and ERCP: A Possible Risk for Patients with Advanced Chronic Pancreatitis. Case Rep Gastroenterol 2012; 6:162.</a></li><li><a class="nounderline abstract_t">Ahmad S, Bragg D, Zaitoun AM, Lobo DN. A dangerous loop. Clin Case Rep 2016; 4:535.</a></li><li><a class="nounderline abstract_t">Del Moral Martínez M, Delgado Maroto A, Cervilla Sáez de Tejada ME, et al. Hepatic hematoma after ERCP: two new case reports. Rev Esp Enferm Dig 2017; 109:470.</a></li><li><a class="nounderline abstract_t">Oliveira Ferreira A, Tato Marinho R, Velosa J. Infected hepatic hematoma 10 days after ERCP. Endoscopy 2013; 45 Suppl 2 UCTN:E402.</a></li><li><a class="nounderline abstract_t">Arya R, Priyadarshi RN, Maji T, et al. Large Hepatic Subcapsular Hematoma Following Endoscopic Retrograde Cholangiopancreatography: A Case Report. Cureus 2022; 14:e21920.</a></li><li><a class="nounderline abstract_t">Montenovo M, Javed E, Bakthavatsalam R, Reyes J. Splenic Subcapsular Hematoma After Endoscopic Retrograde Cholangiopancreatography in a Liver Transplant Recipient: Case Report and Literature Review. Exp Clin Transplant 2017; 15:103.</a></li><li><a class="nounderline abstract_t">Badaoui R, Ouendo M, Delcenserie R, et al. Injury to the liver and spleen after diagnostic ERCP. Can J Anaesth 2002; 49:756.</a></li><li><a class="nounderline abstract_t">Grammatopoulos A, Moschou M, Rigopoulou E, Katsoras G. Splenic injury complicating ERCP. Ann Gastroenterol 2014; 27:177.</a></li><li><a class="nounderline abstract_t">Paredes AH, Williams AM, Vertrees AE, Womeldorph C. Splenic laceration following ERCP. Endoscopy 2013; 45 Suppl 2 UCTN:E221.</a></li><li><a class="nounderline abstract_t">Poon CM, Lee FY, Ko CW, et al. A rare complication of intra-abdominal hematoma after ERCP. Gastrointest Endosc 2002; 56:307.</a></li><li><a class="nounderline abstract_t">Chavalitdhamrong D, Donepudi S, Pu L, Draganov PV. Uncommon and rarely reported adverse events of endoscopic retrograde cholangiopancreatography. Dig Endosc 2014; 26:15.</a></li><li><a class="nounderline abstract_t">Sezgin O, Oğuz D, Altintaş E, et al. Endoscopic management of biliary obstruction caused by cavernous transformation of the portal vein. Gastrointest Endosc 2003; 58:602.</a></li><li><a class="nounderline abstract_t">Nakamura T, Shiokawa M, Nakai Y. Successful Hemostasis of Bleeding From Biliary Varices. Clin Gastroenterol Hepatol 2019; 17:e130.</a></li><li><a class="nounderline abstract_t">Chandra R, Kapoor D, Tharakan A, et al. Portal biliopathy. J Gastroenterol Hepatol 2001; 16:1086.</a></li><li><a class="nounderline abstract_t">Kumar K, Sinha R, Nafe ZM. Post ERCP gastrointestinal hemorrhage: An unusual complication of migrated biliary stent. J Family Med Prim Care 2020; 9:1212.</a></li><li><a class="nounderline abstract_t">Nezu Y, Nakaji S, Fujii H, et al. Pseudoaneurysm caused by a self-expandable metal stent: a report of three cases. Endoscopy 2014; 46:248.</a></li><li><a class="nounderline abstract_t">Mathur S, Thapar V, Chowda V. Hemobilia due to arteriobiliary fistula complicating ERCP for residual bile duct stone in a case of Mirizzi syndrome. Ann Hepatobiliary Pancreat Surg 2017; 21:88.</a></li><li><a class="nounderline abstract_t">al-Jeroudi A, Belli AM, Shorvon PJ. False aneurysm of the pancreaticoduodenal artery complicating therapeutic endoscopic retrograde cholangiopancreatography. Br J Radiol 2001; 74:375.</a></li><li><a class="nounderline abstract_t">Dunne R, McCarthy E, Joyce E, et al. Post-endoscopic biliary sphincterotomy bleeding: an interventional radiology approach. Acta Radiol 2013; 54:1159.</a></li><li><a class="nounderline abstract_t">Zippi M, Hong W, Traversa G. Intramural hematoma of the esophagus: An unusual complication of endoscopic retrograde cholangiopancreatography. Turk J Gastroenterol 2016; 27:560.</a></li><li><a class="nounderline abstract_t">Donepudi S, Chavalitdhamrong D, Pu L, Draganov PV. Air embolism complicating gastrointestinal endoscopy: A systematic review. World J Gastrointest Endosc 2013; 5:359.</a></li><li><a class="nounderline abstract_t">ASGE Standards of Practice Committee, Chandrasekhara V, Khashab MA, et al. Adverse events associated with ERCP. Gastrointest Endosc 2017; 85:32.</a></li><li><a class="nounderline abstract_t">Maggino L, Crinò SF, Bernardoni L, et al. An unforeseeable adverse event during ERCP. Endoscopy 2016; 48 Suppl 1:E278.</a></li><li><a class="nounderline abstract_t">Afreen LK, Bryant AS, Nakayama T, et al. Incidence of Venous Air Embolism During Endoscopic Retrograde Cholangiopancreatography. Anesth Analg 2018; 127:420.</a></li><li><a class="nounderline abstract_t">Voigt P, Schob S, Gottschling S, et al. Systemic air embolism after endoscopy without vessel injury - A summary of reported cases. J Neurol Sci 2017; 376:93.</a></li><li><a class="nounderline abstract_t">Olaiya B, Adler DG. Air embolism secondary to endoscopy in hospitalized patients: results from the National Inpatient Sample (1998-2013). Ann Gastroenterol 2019; 32:476.</a></li><li><a class="nounderline abstract_t">Lanke G, Adler DG. Gas embolism during endoscopic retrograde cholangiopancreatography: diagnosis and management. Ann Gastroenterol 2019; 32:156.</a></li><li><a class="nounderline abstract_t">Maqsood MH, Mirza N, Hanif MA, et al. Clinical Presentation, Diagnosis, and Management of Air Embolism During Endoscopic Retrograde Cholangiopancreatography. Gastroenterology Res 2019; 12:283.</a></li><li><a class="nounderline abstract_t">Mirski MA, Lele AV, Fitzsimmons L, Toung TJ. Diagnosis and treatment of vascular air embolism. Anesthesiology 2007; 106:164.</a></li><li><a class="nounderline abstract_t">Albert JG, Friedrich-Rust M, Elhendawy M, et al. Peroral cholangioscopy for diagnosis and therapy of biliary tract disease using an ultra-slim gastroscope. Endoscopy 2011; 43:1004.</a></li><li><a class="nounderline abstract_t">Efthymiou M, Raftopoulos S, Antonio Chirinos J, May GR. Air embolism complicated by left hemiparesis after direct cholangioscopy with an intraductal balloon anchoring system. Gastrointest Endosc 2012; 75:221.</a></li><li><a class="nounderline abstract_t">Kondo H, Naitoh I, Nakazawa T, et al. Development of fatal systemic gas embolism during direct peroral cholangioscopy under carbon dioxide insufflation. Endoscopy 2016; 48 Suppl 1:E215.</a></li><li><a class="nounderline abstract_t">Hann A, Zizer E, Egger K, et al. Fatal outcome due to CO2 emboli during direct cholangioscopy. Gut 2018; 67:1378.</a></li><li><a class="nounderline abstract_t">ASGE Technology Committee, Lo SK, Fujii-Lau LL, et al. The use of carbon dioxide in gastrointestinal endoscopy. Gastrointest Endosc 2016; 83:857.</a></li><li><a class="nounderline abstract_t">Marchesi M, Battistini A, Pellegrinelli M, et al. Fatal air embolism during endoscopic retrograde cholangiopancreatography (ERCP): An 'impossible' diagnosis for the forensic pathologist. Med Sci Law 2016; 56:70.</a></li><li><a class="nounderline abstract_t">Sisk JM, Choi MD, Casabianca AB, Hassan AM. Two Cardiac Arrests Because of Venous Air Embolism During Endoscopic Retrograde Cholangiopancreatography: A Case Report. A A Case Rep 2017; 8:47.</a></li><li><a class="nounderline abstract_t">Minocha A, Richards RJ. Pneumothorax complicating diagnostic upper endoscopy. Am J Gastroenterol 1999; 94:2323.</a></li><li><a class="nounderline abstract_t">Lehmann V, Keller W, Egger B. Systematic review of pneumothoraces after endoscopic retrograde cholangiopancreatography. Swiss Med Wkly 2020; 150:w20199.</a></li><li><a class="nounderline abstract_t">Gupta A, Zaidi H, Habib K. Pneumothorax after Colonoscopy - A Review of Literature. Clin Endosc 2017; 50:446.</a></li></ol></div><div id="topicVersionRevision">Topic 638 Version 27.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10223360" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective series of claims to insurance covering public hospitals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22414468" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : ERCP procedures in a Finnish community hospital: a retrospective analysis of 1207 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23114747" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Quality assessment of endoscopic retrograde cholangiopancreatography: results of a running nationwide Austrian benchmarking project after 5 years of implementation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30107618" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : [Austrian benchmarking project for ERCP: a 10-year report].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23225493" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Patterns and predictive factors of complications after endoscopic retrograde cholangiopancreatography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17509029" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Incidence rates of post-ERCP complications: a systematic survey of prospective studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34953054" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Endoscopic retrograde cholangiopancreatography-related adverse events in Korea: A nationwide assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23793659" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Endoscopic retrograde cholangiopancreatography: utilisation and outcomes in a 10-year population-based cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27494454" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : All-cause mortality after ERCP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8782497" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Complications of endoscopic biliary sphincterotomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9684657" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11232684" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Complications of diagnostic and therapeutic ERCP: a prospective multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19286178" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17703388" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19098846" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Risk factors for ERCP-related complications: a prospective multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12397271" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Risk factors for complications after performance of ERCP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15557948" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Complications of ERCP: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30416316" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12447281" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Adverse outcomes of ERCP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33654349" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Timing of endoscopic therapy for acute bilio-pancreatic diseases: a practical overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16923479" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Relationship among hospital ERCP volume, length of stay, and technical outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28606848" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Association Between Endoscopist and Center Endoscopic Retrograde Cholangiopancreatography Volume With Procedure Success and Adverse Outcomes: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31060119" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Impact of Hospital Volume and the Experience of Endoscopist on Adverse Events Related to Endoscopic Retrograde Cholangiopancreatography: A Prospective Observational Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12024166" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : ERCP outcomes: defining the operators, experience, and environments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31863440" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17591470" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : A national study of cardiopulmonary unplanned events after GI endoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21316669" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A prospective assessment of sedation-related adverse events and patient and endoscopist satisfaction in ERCP with anesthesiologist-administered sedation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29298872" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Acute sedation-associated complications in GI endoscopy (ProSed 2 Study): results from the prospective multicentre electronic registry of sedation-associated complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31622738" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Complications of Anesthesia Services in Gastrointestinal Endoscopic Procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1307223" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Basket impaction at the pancreatic head.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9101153" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Novel methods of management of trapped dormia baskets in the pancreatic and biliary ducts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27293442" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Impacted and Fractured Biliary Basket: A Second Basket Rescue Technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28785504" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Laparoscopic Common Bile Duct Exploration for Retrieval of Impacted Dormia Basket following Endoscopic Retrograde Cholangiopancreatography with Mechanical Failure: Case Report with Literature Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22361862" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Comparison of endoscopic papillary large balloon dilation and endoscopic sphincterotomy for retrieval of choledocholithiasis: a meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22171149" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Portal vein cannulation: an uncommon complication of endoscopic retrograde cholangiopancreatography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21425030" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Portobiliary fistula: unusual complication of wire-guided cannulation during endoscopic retrograde cholangiopancreatography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17701859" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : [Accidental cannulation of the hepatic artery following needle-knife sphincterotomy].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26693377" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Parenchymal Guidewire Perforation during ERCP: An Unappreciated Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27446851" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Perforation of the Papilla of Vater in Wire-Guided Cannulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29969804" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Successful endoscopic removal of fractured guidewire fragments from a peripheral bile duct using a biliary stent delivery system and biopsy forceps.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37164336" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Successful retrieval of a fractured biliary guidewire using a newly developed endoscopic tapered sheath.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36566740" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Fractured guide wire in the main pancreatic duct during ERCP: A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36159199" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Successful Endoscopic Retrieval of a Retained Fractured Guidewire from the Main Pancreatic Duct.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19275689" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Adverse reactions to iodinated contrast media administered at the time of endoscopic retrograde cholangiopancreatography (ERCP).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29666785" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Risk Evaluation of Endoscopic Retrograde Cholangiopancreatography-Related Contrast Media Allergic-Like Reaction: A Single Centre Experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19028218" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Prospective evaluation of adverse reactions to iodine-containing contrast media after ERCP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16185956" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : ASGE Technology Status Evaluation Report: radiographic contrast media used in ERCP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14702971" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Pyogenic cholangitis after inadvertent submucosal contrast injection in the papilla of Vater in a patient with cholestatic hepatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24139080" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : An update on the management of implanted cardiac devices during electrosurgical procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32804270" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Electromagnetic interference on cardiac pacemakers and implantable cardioverter defibrillators during endoscopy as reported to the US Federal Drug Administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36160813" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Effects of medically generated electromagnetic interference from medical devices on cardiac implantable electronic devices: A review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26867552" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Endoscopic Electrosurgery in Patients with Cardiac Implantable Electronic Devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22679404" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Splenic Injury and ERCP: A Possible Risk for Patients with Advanced Chronic Pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27190626" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : A dangerous loop.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28506070" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Hepatic hematoma after ERCP: two new case reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24285071" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Infected hepatic hematoma 10 days after ERCP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35273865" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Large Hepatic Subcapsular Hematoma Following Endoscopic Retrograde Cholangiopancreatography: A Case Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28004996" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Splenic Subcapsular Hematoma After Endoscopic Retrograde Cholangiopancreatography in a Liver Transplant Recipient: Case Report and Literature Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12193500" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Injury to the liver and spleen after diagnostic ERCP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24733368" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Splenic injury complicating ERCP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23945920" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Splenic laceration following ERCP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12145620" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : A rare complication of intra-abdominal hematoma after ERCP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24118211" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Uncommon and rarely reported adverse events of endoscopic retrograde cholangiopancreatography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14520303" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Endoscopic management of biliary obstruction caused by cavernous transformation of the portal vein.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30114483" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Successful Hemostasis of Bleeding From Biliary Varices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11686833" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Portal biliopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32318497" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Post ERCP gastrointestinal hemorrhage: An unusual complication of migrated biliary stent.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24573734" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Pseudoaneurysm caused by a self-expandable metal stent: a report of three cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28567453" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Hemobilia due to arteriobiliary fistula complicating ERCP for residual bile duct stone in a case of Mirizzi syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11387157" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : False aneurysm of the pancreaticoduodenal artery complicating therapeutic endoscopic retrograde cholangiopancreatography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23892235" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Post-endoscopic biliary sphincterotomy bleeding: an interventional radiology approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27852551" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Intramural hematoma of the esophagus: An unusual complication of endoscopic retrograde cholangiopancreatography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23951390" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Air embolism complicating gastrointestinal endoscopy: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27546389" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Adverse events associated with ERCP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27509474" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : An unforeseeable adverse event during ERCP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29933275" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Incidence of Venous Air Embolism During Endoscopic Retrograde Cholangiopancreatography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28431636" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Systemic air embolism after endoscopy without vessel injury - A summary of reported cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31474794" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Air embolism secondary to endoscopy in hospitalized patients: results from the National Inpatient Sample (1998-2013).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30837788" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Gas embolism during endoscopic retrograde cholangiopancreatography: diagnosis and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31803307" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Clinical Presentation, Diagnosis, and Management of Air Embolism During Endoscopic Retrograde Cholangiopancreatography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17197859" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Diagnosis and treatment of vascular air embolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21823068" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Peroral cholangioscopy for diagnosis and therapy of biliary tract disease using an ultra-slim gastroscope.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21470606" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Air embolism complicated by left hemiparesis after direct cholangioscopy with an intraductal balloon anchoring system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27310894" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Development of fatal systemic gas embolism during direct peroral cholangioscopy under carbon dioxide insufflation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28360098" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Fatal outcome due to CO2 emboli during direct cholangioscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26946413" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : The use of carbon dioxide in gastrointestinal endoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26209631" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Fatal air embolism during endoscopic retrograde cholangiopancreatography (ERCP): An 'impossible' diagnosis for the forensic pathologist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27898548" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Two Cardiac Arrests Because of Venous Air Embolism During Endoscopic Retrograde Cholangiopancreatography: A Case Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10445584" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Pneumothorax complicating diagnostic upper endoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32242910" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Systematic review of pneumothoraces after endoscopic retrograde cholangiopancreatography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28395133" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Pneumothorax after Colonoscopy - A Review of Literature.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
